Helsinki-based start-up Algorithmiq, for instance, says it will be able to demonstrate practical quantum advances in drug development and discovery in five years’ time.
Some firms are so optimistic that they are even promising useful commercial applications in the near future. Helsinki-based start-up Algorithmiq, for instance, says it will be able to demonstrate practical quantum advances in drug development and discovery in five years’ time. “We’re confident about that,” says Sabrina Maniscalco, Algorithmiq’s co-founder and chief executive, and a physicist at the University of Helsinki.